EVOK - Evoke Pharma Inc
11
0.040 0.364%
Share volume: 47,105
Last Updated: 12-16-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$10.96
0.04
0.00%
Summary score
38%
Profitability
50%
Dept financing
12%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
63.82%
Return on assets
-32.49%
Return on sales
0%
Return on invested capital
151.23%
Total debt ratio
44.1%
Debt ratio change over timeo
0%
Current Ratio
5.15%
Quick Ratio
0%
Cash Position Ratio
4.95%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
434.86%
Return on assets
-41.88%
Return on sales
0%
Return on invested capital
92.52%
Total debt ratio
50.61%
Debt ratio change over timeo
0%
Current Ratio
2.59%
Quick Ratio
0%
Cash Position Ratio
2.36%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
1864.56%
Return on assets
-84.25%
Return on sales
0%
Return on invested capital
106.06%
Total debt ratio
104.52%
Debt ratio change over time
0%
Current Ratio
1.23%
Quick Ratio
0%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EVOK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 63.82% | 17.45% | 4.69% | -3.05% |
| Return on assets | -32.49% | 3.37% | 3.35% | 3.6% |
| Return on sales | 0% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 151.23% | 5.2% | 4.37% | 5.09% |
| Profitability | 50% | 50% | 46% | 51% |
| Total debt ratio | 44.1% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 11% | 19% | 18% | 50% |
| Current Ratio | 2.59% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 2.36% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 27% | 35% | 36% |
| Short-term ratios | EVOK | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 434.86% | 44.06% | 6.24% | -25.62% |
| Return on assets | -41.88% | 3.88% | 3.22% | 3.26% |
| Return on sales | 0% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 92.52% | 9.69% | 4.96% | 8.14% |
| Profitability | 50% | 52% | 42% | 48% |
| Total debt ratio | 50.61% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 12% | 22% | 35% | 50% |
| Current Ratio | 2.59% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 0% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 2.36% | 0.17% | 0.53% | 1.48% |
| Liquididy | 50% | 24% | 31% | 61% |